Firn N

Firn N is a prominent Russian biotechnology company specializing in the development, manufacturing, and marketing of innovative recombinant interferon-based pharmaceuticals. Founded in 1989 by Professor Peter Gaponyuk, the company is best known for its flagship product Grippferon, an intranasal interferon alpha-2b formulation widely used for the prevention and treatment of influenza and acute respiratory viral infections. The company's portfolio extends across multiple therapeutic areas, including ophthalmology with Oftalmoferon, dermatology with Gerpferon, and gynecology with Vagisept and Gynoferon. Firn N operates its own research center and state-of-the-art manufacturing facilities in Moscow, holding over 80 patents for its original drug formulations and delivery systems.